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A B S T R A C T  
Objective: To determine plasma adiponectin and leptin levels in subjects with and without ischemic heart disease (IHD) 
and to find the correlation between leptin, adiponectin to the number of coronary vessels disease-using angiography. 
Patients and Methods: This is a cross-sectional study conducted Ziauddin University.  80 subjects were recruited who 
were undergoing angiography. Height, weight, Waist and hip circumference were measured. BMI and WHR were 
calculated accordingly. Venous blood was drawn to measure adiponectin and leptin using ELISA. 
Results: Leptin to adiponectin ratio (LA ratio) was significantly increased in three and two vessel disease compared with 
single vessel and non-significant groups. 
Conclusion: The study shows that adiponectin decreases and leptin increases in multivessel disease. LA ratio has been 
found to correlate well in two and more than two vessel disease. 
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I n t r o d u c t i o n  
 
Cardiovascular disease is the leading cause of death 
worldwide. Genetic tendency, sedentary life style, age, 
hypercholesterolemia, insulin resistance, smoking, 
diabetes mellitus and hypertension are the most common 
determinants for these disorders.1An imbalance between 
oxygen demand and supply to myocardial vessels due to 
atherosclerosis results in coronary artery disease.2 
According to WHO report, prevalence of cardiovascular 
disease is increasing in both developed and developing 
countries.3 By 2020, Pakistan will be ranked  4th most 
heavily populated country in terms of diabetic patients and 
every 3rd person above 45 years of age will be 
hypertensive.4 Since both are risk factors for ischemic 
heart disease, the burden of disease on our population 
can be easily foreseen. People from the Asian 
subcontinent are especially prone to cardiovascular 
disease due to certain risk factors incurred with a variation 
in lifestyle including, lack of a balanced diet, health 
awareness, exercise, and inaccessibility to modernized 
health care.5,6 More specifically, The National Health 
Survey of Pakistan showed that obesity, 
hypercholesterolemia, and atherosclerosis are the most 
important determinants of ischemic heart disease.7 It also 
indicated that increasing prevalence of obesity, 
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hypertension, diabetes, and ischemic heart disease are 
not only due  to diets rich in salt and sugar, but also due 
to the lack of recreational/physical activities.8  Previously 
adipocytes were considered to be an inert storage site for 
triglycerides. In numerous studies adipocytes have now 
been demonstrated to have an endocrinological function 
by which they release two hormones notably, leptin and 
adiponectin, which are thereby termed as 
adipocytokines.9 These hormones are considered 
important in the regulation of cardiovascular function and 
homeostasis.10  
Leptin was one of the first adipocytokine discovered.11 
Leptin is a protein, containing 167 amino acid belonging 
to cytokine family, encoded by Obesity gene at 7q31.3 
locus.12 Adiponectin is a 244-residue protein that is 
produced mainly by white adipose tissue.13  Several 
studies demonstrated that high plasma leptin levels alone 
can indicate acute cardiovascular conditions, reocclusions 
after angioplasty, without association of traditional risk 
factors.14 In contrast to this, low levels of serum 
adiponectin levels (due to genetic and environmental 
causes) results in obesity, type 2 diabetes, metabolic 
syndrome and atherosclerosis. This paradox in leptin and 
adiponectin concentrations suggests that leptin may 
trigger the process of vascular injury while adiponectin 
have protective role in the development of 
atherosclerosis.11 More recently LA ratio is recognized as 
an index of atherogenesis in diabetic patients.15 In this 
study would evaluate the role of LA ratio in ischemic heart 
disease and its correlation with the extent of coronary 
artery disease. 
M: meter, Kg: kilogram, Cm: centimeter, BMI: body mass index, 
WHR: waste hip ratio 
L/A ratio: Leptin to adiponectin ratio 
 
Table 1: Descriptive characteristics of Ischemic 
heart disease patients (n=80) 
Variables Mean±SD Range 
Age (years) 48.81±6.15 35-60 
Height (m) 1.64±0.98 1.45-1.82 
Weight (kg) 73.23±9.32 58-105 
BMI (kg/ m2) 27.23±3.42 20.50-38.10 
Waist 
circumference(cm) 
91.15±7.06 74-107 
Hip circumference(cm) 90.48±6.27 76-102 
WHR 1.01±0.08 0.87-1.20 
 
Figure-1: Graphical distribution of pattern of extent of 
CAD 
 
Figure-2: Graphical representation of mean leptin 
level according to multi vessel disease involvement 
 
Figure-3: Graphical representation of mean 
Adeponectin level according to multi vessel disease 
involvement 
P a t i e n t s  a n d  M e t h o d s  
This cross sectional study was conducted at Ziauddin 
University. Study duration was 2 years. Ethical approval 
was taken from ethical review committee of Ziauddin 
University. Individuals with age range between 40 -55 
years from both genders diagnosed as a patient of CVD 
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on the basis of standard diagnosis protocol including 
ECG, cardiac enzyme and stress tests from angiography 
unit were inducted in the study.  Exclusion criteria was 
Subjects with endocrine disorders or on anti-diabetics or 
lipid lowering drugs. Sampling was done through non-
probability purposive sampling technique. Written consent 
was taken. A detailed history was entered on a detailed 
prescribed study proforma. Height, weight, Waist and hip 
circumference were measured. BMI and WHR were 
calculated by standard formulae. They were classified 
obese if BMI > 30 kg/m2 and non-obese if BMI <30 
kg/m2.16 Waist to hip ratio >0.95 in women and > 0.80 in 
men was considered obese.17 Total 10 ml blood was 
taken by venipuncture at the time of angiography in a 
vacutainer tube. After centrifugation at 3000rpm for 15 
minutes’ serum was stored at -70˚C for future use. 
Samples were analyzed for leptin and adiponectin 
concentrations by using ELISA immunoassay kits (DRG 
diagnostics, Germany). Commercially available ELISA kit 
(DRG instrument GmbH, Marburg, Germany) was used to 
determine plasma adiponectin concentration. 
Manufacturer instructions were followed strictly and all 
tests were performed in duplicate on 96 well plates. 
Adiponectin values were expressed as µg/ml. 
Angiography was performed on TOSHIBA Infinix 2000A. 
Intra coronary guide wire was selected by the operator on 
the basis of coronary anatomy and morphology of the 
lesion. After crossing target lesion, the guide wire was 
fixed and appropriate sized balloon (balloon/artery ratio 
1:1) was advanced to lesion site. After that balloon was 
inflated by inflation device filled with 50% mixture of 
contrast and saline. Data analysis was performed by 
using SPSS (Statistical program for social sciences) 
version-21.0.  
 
Figure-4: Graphical representation of mean L/A ratio 
according to multi vessel disease involvement 
For continuous variables like age, height, weight, BMI, 
waist circumference, hip circumference, WHR, serum 
adiponectin, leptin and LA ratio were presented by mean 
± standard deviation. One-way ANOVA and Post hoc 
Tukey HSD were performed to compare mean level 
among four study groups according to extent of CAD. 
Regression analysis was done to estimate relationship of 
serum levels with extent of CAD. Statistical significance 
was considered if p ≤ 0.05  
R e s u l t s  
Out of 80 subjects, large number of patients (37.5%) had 
one vessel followed by (30%) three vessels CAD (Figure 
1). Table 1 showed basic characteristics of all the 
participants expressed as mean and standard deviation. 
Waist circumference and WHR was significantly more in 
three vessels CAD group (Table 2). Mean serum 
adiponectin level was significantly decreased in 2 & 3 
vessels CAD groups (p<0.001) compared with two other 
groups. High L/A ratio in 3-vessels CAD was observed 
compared with the other three groups (Table 3). Positive 
significant correlation of serum leptin level was found with 
extent of CAD (r = 0.298). Regarding serum adiponectin 
levels, negative but significant correlation was present 
with extent of CAD (r = -.496). LA ratio also showed 
positive significant correlation (r = 0.498) (Table 4). 
(Figure 2) showed that serum leptin levels increased with 
progression of disease. Figure 3 indicates low levels of 
adiponectin with the progression of multi vessels disease. 
L/A also increased as the disease advances from 1 
vessels to 3 vessels stage (Figure 4). 
D i s c u s s i o n  
Our study is focused on the variations in leptin and 
adiponectin levels and the ratio of leptin to adiponectin 
with the extent of occlusion of coronary arteries. 
According to our data serum adiponecctin levels 
decreased significantly with the progression of disease 
that is two vessels or three vessel disease compared with 
one vessel and non-significant group (Table-3). 
Adiponectin has been anticipated to protect against 
cardiovascular diseases. Adiponectin exerts strong anti-
inflammatory effects through nuclear factor κ-B 
pathway,18,19 down regulates adhesion molecules 
expressions on endothelial cells and enhances lipid 
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clearance.20,21 Endothelial dysfunction is the first stage of 
atherogenesis.22 Adiponectin holds protective actions on 
every stage of atherogenesis.23 NO (Nitric Oxide) is the 
key endothelium derived relaxing factor which plays a 
central role in the regulation of vasomotor function  and 
vascular tone. Alteration in NO levels in the endothelium 
mediates anti-inflammatory properties of adiponectin. In 
vitro, adiponectin induces NO production in human aortic 
endothelial cells via activation of MAPK(Mitogen activated 
protein kinase) pathway and enhanced endothelial Nitric 
oxide  synthase mRNA and protein expression10, 24 
Adiponectin is prone to suppress superoxide generation 
and enhances Nitric oxide synthase  activity in endothelial 
cells that are treated with oxidized LDL. Adeponectin is 
reported to down regulate acetyl Co A, Cholesteryl 
acyltransferase-1 in macrophages, thereby reducing the 
formation of foam cells.25  
Our study shows that serum leptin concentration 
increases with the number of vessels involve. Our data 
suggest that there is significant increase in two vessel 
disease and three vessel disease when compared with 
one vessel and non-significant diseases (p value of 
<0.001) Leptin is secreted by white adipose tissues, the 
most frequent form of adipose tissues in mammals.26 
Cardiovascular risk is increasingly implicated by 
increased levels of leptin. Increased leptin levels are well 
associated with obesity related cardiovascular diseases 
such as atherosclerosis.27, 28 Leptin exerts atherogenic 
effects, including endothelial dysfunction,29 smooth 
muscle cell proliferation 30 generation of inflammatory 
mediators and platelet function modulation.31,32 The key 
event which contribute to the formation of atherogenic 
plaque is the formation of lipid laden macrophages.31  
Antagonism of leptin and adeponectin actions on 
cardiovascular system is shown above, there are 
evidences that high plasma leptin and low plasma 
adiponectin levels reflects poor cardiovascular outcome.33 
Kappelle et al proposed L:A ratio is a useful parameter to 
evaluate the cardiovascular event.34 According to Norata 
et al, the L:A ratio can be used as a marker to predict 
thickness of intima media and its possible cardiovascular 
outcome.35 In one study it was found that increased 
peritoneal dialysis patients markedly elevated L: A ratio is 
consistent with high risk for cardiovascular disease.36 
,  
Table 2: Characteristics of Ischemic heart disease patients according to multi vessel disease involvement  
(n=80) 
 
HNS group 
(n=14) 
mean±SD 
One vessel 
CAD 
(n=30) 
mean±SD 
Two vessels 
CAD 
(n=12) 
mean±SD 
Three vessels 
CAD 
(n=24) 
mean±SD 
p-value 
Age (years) 47.42±5.89 49.13±6.62 49.25±5.24 49.00±6.35 0.837 
Height (m) 1.61±0.10 1.62±0.09 1.71±0.09 1.65±0.08 0.024 
Weight (kg) 70.14±14.02 71.76±7.61 77.58±8.69 74.70±7.58 0.138 
BMI (kg/ m2) 26.84±4.65 27.15±3.91 26.30±1.87 28.03±2.41 0.505 
Waist 
circumference(cm) 
85.64±5.74 90.13±5.98 92.66±8.15 94.87±6.33 0.000 
Hip circumference(cm) 89.50±6.72 91.83±7.27 90.66±5.92 89.29±4.65 0.463 
WHR 0.94±0.06 0.98±0.07 1.06±0.04 1.07±0.05 0.000 
 
Table 3: Plasma Levels of Adiponectin, Leptin and L/A ratio according to functioning of multi vessel disease 
(n=80) 
Variables 
HNS group 
(n=14) 
mean±SD 
One vessel CAD 
(n=30) 
mean±SD 
Two vessels CAD 
(n=12) 
mean±SD 
Three vessels CAD 
(n=24) 
mean±SD 
Adiponectin 
(µg/mL) 
5.36±2.41 5.13±3.42 2.96±1.05*,** 2.65±1.03*,** 
Leptin (ng/mL) 9.89±5.53 11.69±9.05 12.55±4.67*,** 16.39±10.9*,**,*** 
L/A Ratio 3.15±5.75 3.08±2.68 5.46±3.95*,** 7.81±6.29*,**,*** 
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Post hoc Tukey HSD was applied 
*p-value < 0.05 -Significant compared with hemodynamically 
non-significant group 
**p-value < 0.05 Significant compared with one vessel disease 
group 
***p-value <0.05 Significant compared with two vessels disease 
group 
Table 4: Spearman’s correlation of CAD group 
with quantitative variables  (n=80) 
Variables 
Correlation 
coefficient® 
p-value 
Leptin (ng/mL) 0.298 0.007 
Age (years) 0.076 0.501 
BMI (kg/ m2) 0.200 0.075 
WHR 0.558 0.000 
Adiponectin (µg/mL) -0.496 <.001 
L/A Ratio 0.498 <.001 
 
C o n c l u s i o n  
LA ratio may be used to assess the cardiovascular status 
of the subjects recommended for angiography by the 
cardiologist. 
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